<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

Rising Healthcare Costs: What Abbott Laboratories Employees Need to Know About Managing Financial Strain in Retirement

image-table

Healthcare Provider Update: Healthcare Provider for Abbott Laboratories: Abbott Laboratories operates as both a developer and provider of various healthcare products and services, focusing on medical devices, diagnostics, nutrition, and pharmaceuticals. Its health care offerings span from advanced medical devices for chronic disease management to diagnostic equipment and nutritional products aimed at enhancing patient care and outcomes. Potential Healthcare Cost Increases in 2026: As we look towards 2026, healthcare costs are anticipated to surge significantly, primarily driven by the expiration of enhanced federal premium subsidies under the Affordable Care Act (ACA). States may implement record-setting premium hikes, with some rates soaring over 60%. Combined with underlying medical cost inflation and aggressive rate increases from major insurers, consumers could face an alarming rise in out-of-pocket costs-potentially over 75% for many policyholders. This scenario underscores the pressing need for individuals to strategically prepare for the financial landscape in the coming years. Click here to learn more

Receiving a cancer diagnosis is devastating news that not only compromises one's health but also causes significant financial strain. For many patients, the financial hardship brought on by increased out-of-pocket expenses, declining incomes, and higher drug prices can be overwhelming. This article examines the substantial financial toll that cancer has on Americans and Abbott Laboratories employees, focusing on individual experiences, data, and the wider ramifications of this expanding epidemic.

The Story of Gwendolyn Jackson and the Personal Toll of Cancer

Gwendolyn Jackson had no problems paying her bills before being diagnosed with cervical cancer. She owned her house, had insurance, and worked for a living. But when she was 53 years old, her life changed drastically when she was told she had cervical cancer. Jackson lost her work as a housing coordinator due to the physical toll of chemotherapy and a subsequent stroke, and she is already facing tens of thousands of dollars in medical debt. Her vehicle was repossessed, and she received an eviction notice.

Jackson recalls, 'I woke up one morning, and I was a top case manager. Then I was losing everything.'

Increasing Prices and Economic Difficulties

The soaring prices of drugs and medical care are making cancer a more financially burdensome disease in the United States. Iqvia's Institute for Human Data Science estimates that 55% of cancer medications launched between 2019 and 2023 will cost at least $200,000 a year. Patients of working age, including those at Abbott Laboratories, face several difficulties and are more likely to report financial hardship after diagnosis.

Approximately 60% of cancer survivors of working age report having money problems. Many struggle to pay for medical care, frequently leading to debt accumulation—payday loans, credit card debt, etc. Nearly 40% of medical GoFundMe efforts are related to cancer.

Radiation oncologist Dr. Reshma Jagsi of Emory University School of Medicine and the Winship Cancer Institute says, 'We do not want to believe that people with cancer in this country have to cut back on medications, doctor visits, lose their home, or cut back on food.'

The Financial Toxicity Concept

Financial toxicity refers to the challenging financial burden that cancer causes. Treatments, including costly medications, start right away, and there are several non-medical expenses involved. Patients who receive chemotherapy and other treatments frequently become too weak to work, losing their employer-sponsored health insurance and income. The financial consequences may last for many years. Unexpected medical expenses can be devastating in retirement. As Abbott Laboratories Employees planning for these unexpected expenses is curcial.  

Dr. Fumiko Chino, a radiation oncologist at Memorial Sloan Kettering Cancer Center, adds, 'It can cause this wealth shock that can ripple on.' Her husband passed away from cancer over ten years ago, and she still receives calls from debt collectors regarding his outstanding bills. She witnessed the financial burden personally.

The Growing Price of Anticancer Drugs

The growing expense of healthcare and cancer medications is a primary issue affecting Abbott Laboratories employees. These costs are surpassing inflation or having exorbitant initial prices. List prices for common cancer medications can approach six digits. For instance, Medicare beneficiaries will have to pay an average of $5,247 out-of-pocket for the leukemia therapy Imbruvica in 2022, which costs over $213,000 annually. The list price of the lung cancer medication Tagrisso is approximately $208,000 per year.

Some employer-backed plans require patients to pay a portion of the drug costs, shifting the burden of rising healthcare costs onto patients. For cancer patients of working age who had private insurance, out-of-pocket expenses rose by 15% between 2009 and 2016. Patients often have to pay extra for parking, hotel, child care, and transportation.

Featured Video

Articles you may find interesting:

Loading...

The Broader Effect on Earnings

Beyond treatment costs, cancer has a severe financial impact on sufferers' quality of life. A cancer diagnosis forces many to take time off work or quit their jobs completely. Within four years, patients receiving chemotherapy have a higher chance of quitting than those not receiving it. Families as a whole are frequently affected by this burden, with relatives offering care or financial support.

The hardship faced by Erica Olenski is illustrative. In 2019, Olenski's young son August was diagnosed with brain cancer. As a result, she drastically cut back on her working hours, traveling back and forth between McKinney, Texas, and Dallas for August's treatments, which involved weekly hospital stays. The family's income was lowered even though Medicaid paid for the medical expenses.

'It was the transport, gas, tolls, food at the hospital because you can't buy groceries like you would at home,' says Olenski. 'There's a pragmatic reality of living that lifestyle that carries an enormous cost.'

Financial Repercussions and Insolvency

Financial strain often has serious repercussions for Abbott Laboratories employees, sometimes including bankruptcy. Eventually, Olenski had to liquidate the majority of her 401(k) to pay debts. She later got divorced and lost $20,000 throughout the divorce process. In 2023, August's illness returned, and she had to rely on credit cards to pay for necessities like her car and mortgage. She eventually filed for bankruptcy, owing more than $100,000.

'I can only feel proud of myself for weathering the storm as long as I did,' she says.

Cancer's Wider Financial Effects

Research by Dr. Scott Ramsey, director of the Hutchinson Institute for Cancer Outcomes Research at Fred Hutchinson Cancer Center, indicates that individuals with cancer are more likely to have late credit card payments, mortgage defaults, and other financial difficulties compared to non-cancer patients. Individuals who incur more out-of-pocket expenses are more inclined to delay starting their prescriptions or quit completely. According to Ramsey's research, there is an 80% increased chance of death for cancer patients who file for bankruptcy compared to those who do not.

'There actually was a pretty big detriment for survival,' he says.

Gwendolyn Jackson's Persistent Battle

When Jackson's father was diagnosed with lung cancer ten years ago, she saw firsthand the financial toll that cancer takes. Inspired by families who had to sell their jewelry and savings to pay for treatment, she founded a charity organization to assist cancer patients and their families. She is currently in a comparable situation.

Her diagnosis has significantly changed Jackson's life. Her lifestyle has changed from social events and daily jogs to a never-ending schedule of medical visits. Her 83-year-old mother spent $800 a month on her health insurance until it became unaffordable after quitting her job in 2022. Jackson then chose a less expensive insurance plan, but the costs for tests, chemotherapy, and physical therapy continued to mount.

While waiting for long-term disability, she maxed out her credit cards and depended on friends and relatives for financial support. She moved in with her daughter and shared a room with her grandson after losing her house and car.

'It broke me,' Jackson claims.

When Jackson couldn't, Darian Butler, Jackson's 31-year-old daughter, took on a second job to support her mother and help with the organization. Jackson remarks, 'I feel like her life has been stolen from her. I just feel like such a burden sometimes.'

Looking for Guidance and Assistance

Despite substantial breaches in the safety net, campaigners and physicians are searching for patchwork solutions in response to the increasing problems. Patients who are having financial difficulties can now receive support from more cancer facilities, and charitable organizations can help with other requirements like food and travel. Funding is scarce, though, and many patients are not aware of these options. Few patients who use crowdsourcing websites such as GoFundMe are able to meet their financial goals.

Jackson first applied for aid from several organizations, but her income level was used to determine her eligibility. She made the difficult decision to forgo using cash from her nonprofit. She couldn't keep up with the demands, and her attempts to find remote work failed.

Jackson currently receives disability benefits, so she helps pay for groceries, gas, utilities, and her prescription drugs. She was just informed that she will shortly be eligible for Medicare, but she still owes roughly $38,000 in medical debt and cannot afford to pay it after her monthly costs are met.

Jackson's cancer stopped responding to chemotherapy, so she is still being treated through a clinical trial. Despite having just roughly a year and a half to live, debt collectors keep contacting her regarding unpaid medical expenses.

'They'll give you calls and letters,' she continues. 'But I can't pay what I don't have.'

In Summary

The financial toll that cancer takes on American households is significant and widespread. High prescription costs, out-of-pocket spending, and diminished incomes combine to produce a financial burden that many patients and their families find difficult to handle. Narratives from individuals such as Gwendolyn Jackson and Erica Olenski underscore the pressing need for enhanced monetary assistance and strategies to mitigate the economic burden associated with cancer. Addressing this issue is increasingly important as the expense of cancer treatment rises, ensuring that patients can focus on their health without worrying about financial hardship. It is important for Abbott Laboratories employees to always be prepared for any unexpected medical expenses. 

Medicare enrollees paid $5,460 on average out-of-pocket for healthcare in 2021, according to a recent Kaiser Family Foundation report released in May 2023.  The expenditures of healthcare were much greater for people with serious illnesses like cancer. These costs have the potential to rapidly deplete retirement funds, emphasizing the crucial need to comprehend and budget for healthcare expenses in later life.  Retirees may experience financial difficulties that jeopardize their financial security and standard of living when healthcare costs rise (KFF, 2023).

Disclosure: This information is not intended as recommendation. The opinions are subject to change at any time and no forecasts can be guaranteed. Investment decisions should always be made based in investor's specific circumstances. Investing involves risk, including possible loss of principal.

How does the Abbott Laboratories Annuity Retirement Plan (ARP) determine the eligibility requirements for employees, and how can potential changes in federal regulations impact these requirements? Employees of Abbott Laboratories may need to understand the nuances of eligibility, particularly regarding age and service criteria. Changes in laws governing retirement benefits could pose questions about continued eligibility and could affect when employees can begin pension payments.

Eligibility Requirements & Impact of Federal Regulations: Employees at Abbott Laboratories become eligible for the ARP by being part of a participating division, being at least 21 years old, and residing in the U.S. (with certain exceptions for U.S. employees abroad). Changes in federal regulations could potentially alter these eligibility criteria, especially since such rules often influence age and service requirements for retirement plans. Any changes in legislation regarding retirement benefits might necessitate adjustments in eligibility rules, affecting when employees can begin receiving pension payments.

Can you explain the significance of Vesting Service in the context of the Abbott Laboratories Annuity Retirement Plan? Employees often wonder how their years of service influence their benefit eligibility and the amount they can expect. Understanding the elements that constitute Vesting Service, and the implications of terminating employment before achieving vesting, is crucial for Abbott Laboratories employees planning for retirement.

Significance of Vesting Service: Vesting Service at Abbott Laboratories refers to the time an employee must accumulate to gain entitlement to pension benefits, irrespective of continued employment. This service is critical as it determines the security of an employee's future benefits and the degree of an employee's investment in the company's pension plan. Employees who terminate employment prior to achieving full vesting lose entitlement to accrued pension benefits, making understanding and accruing Vesting Service essential for long-term financial planning.

In what ways does the calculation of Final Average Pay play a role in determining retirement benefits under the Abbott Laboratories Annuity Retirement Plan? The methodology used to calculate an employee's Final Average Pay can significantly impact the retirement income they receive. Employees at Abbott Laboratories should consider how their earnings history and the inclusion or exclusion of certain payments factor into their anticipated benefits.

Role of Final Average Pay in Benefit Calculation: Final Average Pay (FAP) is crucial in determining the pension benefits under the ARP as it represents the average of an employee’s highest earnings over a specified period. Abbott’s ARP calculates pension based on a percentage of the FAP, multiplied by years of eligible service. This calculation means that higher earnings towards the end of an employee's career can significantly increase the pension benefits, incentivizing employees to maximize their earnings potential in their final working years.

What optional forms of payment are available to employees upon retirement under the Abbott Laboratories Annuity Retirement Plan, and how do these choices affect overall pension benefits? Abbott Laboratories employees need to evaluate whether to choose single or joint survivor annuities, among other options, as these decisions can have long-term financial implications for both themselves and their beneficiaries.

Optional Forms of Payment at Retirement: The ARP offers various payment options upon retirement, including single and joint survivor annuities, which affect the benefit's distribution and longevity. These choices impact financial planning for retirement, particularly in ensuring that a spouse or beneficiary may continue to receive benefits after the retiree's death. The selection between these options should align with personal financial needs and considerations for dependents' security.

Different employees may have varying perspectives on the importance of early retirement options offered by Abbott Laboratories. What are the qualifications for early special retirement, and how does this option affect retirement income? Employees contemplating retirement before the standard age should understand how factors such as age, years of service, and the specific provisions of the Abbott Laboratories Annuity Retirement Plan influence their benefits.

Early Retirement Qualifications and Impacts: Early retirement under the ARP is available to employees who meet specific age and service criteria, allowing them to retire with reduced benefits before reaching the normal retirement age. This option can significantly affect retirement income, depending on the number of years ahead of normal retirement age the employee chooses to retire, making it crucial for employees to understand the financial trade-offs involved in retiring early.

How does the Abbott Laboratories Annuity Retirement Plan ensure compliance with the Employee Retirement Income Security Act (ERISA), and what rights do employees have under this act? Abbott Laboratories employees should be informed about their rights regarding plan documentation, required disclosures, and recourse in the event of disputes pertaining to their retirement benefits.

ARP Compliance with ERISA: The ARP is designed to comply with the Employee Retirement Income Security Act (ERISA), providing employees with rights to information about plan features and funding, benefits accrual, and recourse in case of disputes. Compliance with ERISA ensures that employees' retirement benefits are protected under federal law, offering a framework for security and transparency in their retirement planning.

How do Abbott Laboratories employees who experience a medical leave of absence or disability maintain their retirement service credits under the Annuity Retirement Plan? Understanding the interaction between long-term disability benefits, medical leave, and retirement plan participation is essential for employees navigating health-related issues while planning for their retirement.

Impact of Medical Leave or Disability on Retirement Credits: Employees on medical leave or disability continue to accrue service credits under the ARP, ensuring that such periods do not adversely affect their pension benefits. This protection helps employees who are temporarily unable to work due to health issues maintain their trajectory towards earning full retirement benefits.

Given the potential for changes to the Abbott Laboratories Annuity Retirement Plan, how can employees stay informed about their rights and any modifications to the plan’s terms? Employees at Abbott Laboratories should have access to reliable communication channels, including how to receive updates about the retirement plan, which could impact their financial planning.

Staying Informed About Plan Changes: Employees can stay informed about changes to the ARP through regular communications from Abbott Laboratories, access to updated plan documents, and direct inquiries to the Abbott Benefits Center. Staying proactive in seeking information and understanding the implications of plan modifications is essential for effective retirement planning.

What processes should Abbott Laboratories employees follow if they wish to obtain a statement regarding their entitlement to a pension? Employees looking to plan for retirement need clear instructions on how to request this crucial information and understand its importance in their long-term financial strategy.

Obtaining a Pension Statement: Employees wishing to obtain a statement of their pension entitlements under the ARP should contact the Abbott Benefits Center. Clear instructions on how to request this information are crucial for employees to plan accurately for retirement and understand their accrued benefits.

If an employee at Abbott Laboratories has further questions about the Annuity Retirement Plan or requires clarification on the document contents, how can they effectively contact the appropriate department? Knowing how to reach out to Abbott Laboratories' Benefits Center regarding retirement plan inquiries is vital for all employees wanting to confirm their understanding or seek additional information about their retirement benefits.

Contacting the Appropriate Department for Plan Inquiries: For further inquiries or clarification regarding the ARP, employees should contact the Abbott Benefits Center. Knowing the correct contact information and how to reach out effectively is vital for resolving concerns and gaining a deeper understanding of their retirement benefits.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Abbott Laboratories offers an Employee Stock Purchase Plan (ESPP) that allows employees to purchase company stock at a discounted price through automatic payroll deductions. This plan operates in two periods: an "offering period" where payroll deductions accumulate, and a "purchase period" where those deductions are used to buy Abbott/AbbVie stock. The ESPP is a qualified plan, meaning contributions are made on a pre-tax basis, allowing for tax-deferred growth. Employees can benefit from lower taxes on gains if they hold the stock for at least one year and sell it at least two years after the offering date. This plan helps employees benefit from the company's performance while also providing tax savings. 401(k) Plan - Stock Retirement Plan (SRP) Abbott's 401(k) plan, known as the Stock Retirement Plan (SRP), provides a significant company match. Employees who contribute 2% of their gross pay receive a 5% company match. In 2022, employees can contribute up to $20,500 annually ($27,000 if over age 50), with employer and employee contributions capped at a combined $61,000 ($67,500 if over 50). Contributions are automatically deducted from paychecks, deferring taxes until retirement when the employee might be in a lower tax bracket. Additionally, Abbott’s Freedom 2 Save program automatically contributes up to 5% of an employee’s gross salary to the SRP plan if the employee contributes at least 2% of their income to student loan repayment. This generous matching scheme and additional programs can help employees build substantial retirement savings over time. [Source: Abbott Benefits Guide, 2022, p. 10]
Abbott Laboratories has announced significant layoffs in 2024, including the closure of its Fairfield plant, which will result in nearly 200 job losses due to cost-cutting measures. This comes amidst a broader trend of job cuts in their medtech and diagnostic divisions, particularly as demand for COVID-19 tests diminishes. Additionally, Abbott is cutting 3,000 jobs globally as part of a restructuring effort to streamline operations and improve efficiencies. This news is critical for stakeholders to understand the economic and political pressures influencing these decisions, including rising inflation, shifts in demand for healthcare products, and strategic moves to maintain financial stability in a volatile market​ (Hoodline)​​ (MedTech Dive)​​ (FierceBiotech)​​ (FiercePharma)​​ (Press Herald)​.
Abbott Laboratories offers stock options and RSUs to align employee interests with company goals. Stock options are granted with a predetermined price and vesting period, while RSUs vest over a few years based on performance or tenure. In 2022, Abbott enhanced its equity programs, emphasizing performance-based RSUs. The trend continued in 2023 and 2024, with broader RSU availability and performance-linked stock options. Executives and middle management are the primary recipients, fostering long-term alignment with company performance. [Source: Abbott Annual Reports 2022-2024, p. 34] Abbott’s RSU program provides employees with shares of company stock subject to a vesting schedule based on performance milestones or years of service. Once vested, RSUs convert to stock, and their fair market value is taxed as ordinary income. Proper tax planning around RSUs is crucial to minimize tax liability, as vesting can significantly impact income and tax brackets. Employees need to decide whether to hold or sell the stock after it becomes available, considering that selling within one year of conversion results in higher tax rates compared to long-term capital gains rates for stock held for more than a year. Integrating RSUs into a comprehensive wealth management plan is essential for maximizing their benefits.
New call-to-action

Additional Articles

Check Out Articles for Abbott Laboratories employees

Loading...

For more information you can reach the plan administrator for Abbott Laboratories at 1295 state street Springfield, MA 1111; or by calling them at 1-866-329-6277.

https://cache.hacontent.com/ybr/R516/00472_ybr_ybrfndt/downloads/EmpHandbook.pdf - Page 12,https://abbottbenefits.com/wp-content/uploads/BenefitsHighlightsGuide_2024.pdf - Page 7,https://cache.hacontent.com/ybr/R516/00472_ybr_ybrfndt/downloads/RetirementGuide2023.pdf - Page 22,https://cache.hacontent.com/ybr/R516/00472_ybr_ybrfndt/downloads/HealthcareOptions2024.pdf - Page 19,https://abbottbenefits.com/wp-content/uploads/2023/01/BenefitsHighlightsGuide_2023.pdf - Page 14,https://abbottbenefits.com/wp-content/uploads/2022/05/BenefitsHighlightsGuide_2022.pdf - Page 8,https://cache.hacontent.com/ybr/R516/00472_ybr_ybrfndt/downloads/AbbottAnnuityRetirementPlan.pdf - Page 11,https://cache.hacontent.com/ybr/R516/00472_ybr_ybrfndt/downloads/AbbottAbbVieMEPP.pdf - Page 25,https://abbottbenefits.com/wp-content/uploads/2024/02/BenefitsCenterGuide.pdf - Page 16,https://www.abbott.com/content/dam/abbott/en-us/documents/pdfs/annual-report-2023.pdf - Page 55

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Abbott Laboratories employees